Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68001-686

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68001-686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol Succinate Er Tabs 100s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 100mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg by BluePoint Laboratories. The label shows the NDC 68001-686-00 and indicates the package contains 100 tablets. It includes storage instructions, manufacturer information from Yichang Humanwell Oral Solid Dosage Plant, and a barcode.*

FDA Label Image

Metoprolol Succinate Er Tabs 500s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 100mg 500s)

Metoprolol Succinate Extended-Release Tablets USP 100 mg label from BluePoint Laboratories. The label states the tablet strength as 100 mg metoprolol succinate equivalent to 100 mg metoprolol tartrate. It indicates 500 tablets in the container. The label includes storage instructions, a warning to keep out of reach of children, and manufacturer information listing Yichang Humanwell Oral Solid Dosage Plant in China, made for BluePoint Laboratories, product of Spain. The NDC number 68001-686-03 is shown along with a barcode.*

FDA Label Image

Metoprolol Succinate Er Tabs 200mg 100s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 200mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg, oral extended-release tablets in a package of 100 tablets. The label indicates the product is manufactured for BluePoint Laboratories and provides storage instructions and warnings. The label includes the NDC 68001-687-00 and specifies it is a prescription drug.*

FDA Label Image

Metoprolol Succinate Er Tabs 25mg 100s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 25mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 25 mg strength, 100 tablets per container. The label includes the NDC 68001-684-00, dosage form as extended-release tablets for oral use, and the manufacturer details, Yichang Humanwell Oral Solid Dosage Plant for BluePoint Laboratories. It also states storage instructions and child-resistant packaging.*

FDA Label Image

Metoprolol Succinate Er Tabs 25mg 500s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 25mg 500s)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength, oral tablet form. The label indicates a package size of 500 tablets and shows the NDC 68001-684-03. Manufactured by Yichang Humanwell Oral Solid Dosage Plant for BluePoint Laboratories. The product is labeled as prescription only and includes storage instructions and a barcode.*

FDA Label Image

Metoprolol Succinate Er Tabs 50mg 100s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 50mg 100s)

Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength, containing 100 tablets. The label includes storage instructions, manufacturer details (Yichang Humanwell Oral Solid Dosage Plant, China), and indicates the product is for BluePoint Laboratories. It features a barcode and states the package is child-resistant.*

FDA Label Image

Metoprolol Succinate Er Tabs Labels 50mg 500s (Metoprolol Succinate Er Tabs Labels Rev 9 2025 50mg 500s)

Label for Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, oral tablet, extended release. The package contains 500 tablets. Labeler is BluePoint Laboratories. The label includes storage instructions, a warning to keep out of reach of children, and notes the product is child-resistant. It also shows the NDC 68001-685-03 and manufacturing details from Yichang Humanwell Oral Solid Dosage Plant, China, for BluePoint Laboratories, product of Spain.*

FDA Label Image

Picture-1 (Picture 1)

A forest plot titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for metoprolol succinate extended release tablets versus placebo. It compares total mortality, total mortality or all-cause hospitalization (time to first event), and total mortality or hospitalization for heart failure (time to first event) across various patient subgroups such as US, non-US, NYHA classes, ejection fraction, etiology, sex, race, prior myocardial infarction, diabetes status, hypertension status, and heart rate groups.*

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol succinate, the active ingredient in the drug Metoprolol Succinate. The diagram shows the molecular structure including the aromatic ring and succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.